News & Events about Provention Bio Inc.
Provention Bio, Inc. (NASDAQ:PRVB Get Rating) major shareholder Sessa Capital (Master), L.P. sold 3,000,000 shares of the businesss stock in a transaction that occurred on Wednesday, January 18th. The shares were sold at an average price of $9.40, for a total transaction of $28,200,000.00. Following...
Provention Bio, Inc. (NASDAQ:PRVB Get Rating) insider Francisco Leon sold 187,000 shares of Provention Bio stock in a transaction on Thursday, December 29th. The shares were sold at an average price of $10.26, for a total value of $1,918,620.00. Following the sale, the insider now directly ...
Provention Bio, Inc. (NASDAQ:PRVB Get Rating) has earned a consensus rating of Buy from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages ...
Latest Ratings for PRVB
DateFirmActionFromTo Aug 2021OppenheimerMaintainsOutperform Aug 2021HC Wainwright & Co.MaintainsBuy Apr 2021Chardan CapitalMaintainsBuy
View More Analyst Ratings for PRVB
View the Latest Analyst Ratings
read more...